Skip to Content

Publications

Fall 2013: Looking beyond the cancer cell, preparing for health care reform, analyzing bevacizumab for glioblastomas, general internal medicine, Children's Art Project's 40th anniversary, and much more.


Cover story

Looking beyond the cancer cell:
Seed, soil and metastasis

In 1889, Stephen Paget, an English surgeon and pathologist, hypothesized that metastasis (the spread of cancer) did not occur randomly. It took nearly a century before Isaiah Fidler came along to prove him right.

Departments

Frontline: A drug. A disease. Three studies. Four investigators.

Picture this: Children's Art Project celebrates 40th anniversary.

Cancer briefings:

Sign of Hope: 

Specialty shop caters to cancer patients

Moving forward: Wyatt McSpadden

Lymphoepithelioma survivor behind the lens again.

PDFs

Page-turning PDF

Standard PDF

Conquest iPad app

Check out Conquest magazine on your Apple iPad to learn the latest in cancer treatment, research, prevention and education.

Download the new Conquest app from the iTunes App Store.

Features

Creating an umbrella of care

Patients in cancer treatment often have other health issues that can affect treatment and/or quality of life. Over the past 25 years, 
MD Anderson has added myriad services to handle these conditions while providing quality care for patients.

 

Preparing for health care reform

With the passage of the Affordable Care Act in 2010 and most provisions due to take effect in 2014, it’s reasonable to ask what MD Anderson is doing to prepare.


Brain waves, eating habits and lipids

As obesity is increasingly referred to as a disease in itself, causing deaths that might have been prevented, MD Anderson experts are searching for ways to prevent the condition. 


The GSBS story: 50th anniversary

As the graduate school celebrates its 50th anniversary, its two leaders assess their first year as deans and look forward to an exciting future. 


Epigenetics, a path to new therapies

Some might call it fate that three scientists came together at MD Anderson to speed research and drug development in the relatively new area of epigenetic marks, damage to which — unlike DNA mutations — can be reversed.